MAINCAV presented by @shilpaonc@caseccc. Important study for its time - imperative to support cooperative group studies
💊 Addition of cabozantinib to avelumab for 1L maintenance for mUC
🛑 Closed early due to tx landscape changes
➖ No OS or PFS benefit with cabozantinib
In an international, randomized trial involving patients with acute venous thromboembolism, the risk of clinically relevant bleeding was significantly lower with apixaban than with rivaroxaban during the 3-month treatment period.
Full COBRRA trial results: nejm.org/doi/full/10.1056/NE…
Confused about all the new data in GU Oncology?
Looking for a fun night at a great venue with friends, colleagues, & networking opportunities?
Join us Thursday (12/18/25) at The House of Blues Cleveland: @OncLive State of the Science Summit GU Cancers biturl.top/ruM3ey
Confused about all the new data in GU Oncology?
Looking for a fun night at a great venue with friends, colleagues, & networking opportunities?
Join us Thursday (12/18/25) at The House of Blues Cleveland: @OncLive State of the Science Summit GU Cancers biturl.top/ruM3ey
🗣️See you in clinic after you get stronger at rehab, to restart chemo
🤔How often does this actually happen?
🚨 My fellowship passion project was just published in @JCOOP_ASCO looking at this question
Tl;dr it depends. A 🧵
ascopubs.org/doi/10.1200/OP-…
Great to have @ReckampK from @CedarsSinai at @CleClinicMD give our annual Bruell Lecture in honor of Ernest Bruell. Discussing optimizing clinical trial design for lung cancer @jamecancerdoc
Breaking news from #ESMO25 in Berlin 👉Randomized trial of Pluvicto/Lu-177 vs. docetaxel (DOC) in 199 pts with mCRPC #prostatecancer 👉progressing after ARPI therapy👉Similar PFS (primarily endpoint) but higher OS with docetaxel👇#KimChi#ESMO25@OncoAlert@urotoday@PCF_Science
OPTIC RCC study shows excellent response to nivo/cabo in patients selected by RNA signature. Grateful to have participated at @UHhospitals@caseccc@PBarataMD#ESMO25
PSMAddition trial is positive for PFS benefit in mHSPC presented by @DrScottTagawa#ESMO25
☢️ Lu-177-PSMA-617 given with to ADT and ARPI (abi most common)
🎇 HR 0.72 for PFS
👦 No OS benefit but data immature
🙅 Crossover allowed
☠️ Higher toxicity with radioligand
Ready to help shape the future of Cardio-Oncology and clonal hematopoiesis (CHIP)? Launching new investigations at @ClevelandClinic and looking for driven residents/fellows to join. If you’re eager to make an impact in this fast-growing field, reach out: oreno2@ccf.org
‼️Happy to announce that @PBarataMD and I are co-hosting the 1st joint GU cancer patient event in Cleveland @UHhospitals@CleClinicMD
📅 Sept 20, 9–12
📍 Rocket Arena, Cleveland
➡️ Lively discussions
➡️ Patient family voices
➡️ Advancing science together
@caseccc#StrongerTogether
Register using the QR code👇👇👇👇
We are excited to welcome Dr. Evandro Bezerra to @ClevelandClinic Lymphoma Program ! Prior to joining @ClevelandClinic he was an Assistant Professor at @OhioState He completed his fellowship in Hematology and Medical oncology from @MayoClinic
Congrats to Dr Underwood, a urologic oncology surgeon, on his election! @wunderwil Looking forward to working together to promote the art and science of medicine and the betterment of public health! Would love to have you come visit us in Cleveland @AmerMedicalAssn
Please join us in congratulating the newest President-elect of #OurAMA, @wunderwil! Dr. Underwood, III, MD, MSc, MPH is a board-certified urologic surgeon based in Buffalo, New York. #AMAmtg
Today’s action to remove the 17 sitting members of ACIP undermines trust and upends a transparent process that has saved countless lives. With an ongoing measles outbreak and routine child vaccination rates declining, this move will further fuel the spread of vaccine-preventable illnesses. spr.ly/60174Huez
Had the privilege of chairing Reference Committee C (Medical Education) for this years @AmerMedicalAssn Annual Meeting. Had a great cmte and great AMA staff support. Loved sharing our work with the House today to develop policy for med ed!